Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats - PubMed (original) (raw)

Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats

R A Yokel et al. Psychopharmacology (Berl). 1976.

Abstract

Norepinephrine (NE) and dopamine (DA) receptor blockade differentially affected amphetamine self-administration. DA blockade (pimozide, 0.0625 to 0.5 mg/kg, or (+)-butaclamol, 0.0125 to 0.1 mg/kg) caused periods of increased rate of responding for amphetamine which were followed, in the case of higher doses, by response cessation. The response cessation produced by 0.5 mg/kg pimozide was not reversed by non-contingent amphetamine injections until well after the peak effect of the pimozide was over. When access to amphetamine injections was delayed until 4 h after animals received 0.5 mg/kg pimozide, rate of responding was elevated. Thus DA seems to be critically involved in mediation of the reinforcing effects of amphetamine. Alpha-NE blockade with phentolamine (2.5-10 mg/kg) produced dose-related decreases in responding; blockade with phenoxybenzamine (1.25-10 mg/kg) had no effect. Beta-NE blockade with l-propranolol (2.5-10 mg/kg) decreased responding, although probably not through a beta-blocking action. The effects of phentolamine and propranolol do not appear to result from attenuation of the reinforcing effects of amphetamine.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharm Pharmacol. 1975 Jul;27(7):540-2 - PubMed
    1. Psychopharmacologia. 1967;11(4):300-10 - PubMed
    1. J Pharmacol Exp Ther. 1968 May;161(1):122-9 - PubMed
    1. Science. 1975 Feb 14;187(4176):547-9 - PubMed
    1. Pharmacol Biochem Behav. 1974 Sep-Oct;2(5):563-71 - PubMed

MeSH terms

Substances

LinkOut - more resources